Examination and Identification of distinct and shared proteomic profiles linked to Alzheimer's Disease biomarkers across multiple proteomic platforms
Hubert Leo, Joshua L Gills, Omonigho M Bubu

TL;DR
This study compares different proteomic platforms to identify shared protein patterns linked to Alzheimer's disease biomarkers in blood samples.
Contribution
The study identifies shared proteomic profiles across platforms for Alzheimer's biomarkers, revealing common pathways like inflammation and cell adhesion.
Findings
Aβ42 had the most intersecting proteins (268) across platforms, while NEFL and GFAP also showed significant correlations.
Common pathways included cytokine-cytokine interaction, insulin signaling, and MAPK signaling across platforms.
Alamar ATN & I biomarkers showed moderate to strong correlations with proteins related to inflammation and cell membrane integrity.
Abstract
Plasma biomarkers like Aβ42/Aβ40, p‐tau isoforms, and NfL are crucial for assessing Alzheimer's disease (AD) pathology. Advanced platforms such as SomaScan 11k, Olink 5k, and ALAMAR (NULISA‐based) enable precise protein measurement. We examined associations between Alamar's NULISA proteins related to AD (ATN & I) with SomaScan and Olink proteins and conducted pathway enrichment analysis to identify proteomic profiles linked to AD biomarkers. This cross‐sectional study used plasma samples from 116 ARIC cohort participants (age 74.3 ± 4.7 years, 88.8% cognitively normal). ATN & I biomarkers included: A (Aβ proteinopathy) – Aβ‐42, Aβ‐40, and Aβ‐42/40; T (phosphorylated and secreted AD tau) ‐ p‐tau217, p‐tau181, p‐tau231 and their ratios with Aβ‐42; N (neuropil injury) – NfL and Total Tau; and I (inflammation) – GFAP. Biomarkers were quantified using the ALAMAR NULISA platform and compared…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAlzheimer's disease research and treatments · Advanced Proteomics Techniques and Applications · Dementia and Cognitive Impairment Research
